Vir Biotechnology, Inc. (VIR)
8.505
+0.06
(+0.65%)
USD |
NASDAQ |
Jun 09, 16:00
8.21
-0.30
(-3.47%)
After-Hours: 19:15
Vir Biotechnology Total Liabilities (Quarterly) : 212.82M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 295.31M |
| Revolution Medicines, Inc. | 753.82M |
| Kymera Therapeutics, Inc. | 129.38M |
| Arrowhead Pharmaceuticals, Inc. | 1.669B |
| Oncolytics Biotech, Inc. | 13.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.026B |
| Shareholders Equity (Quarterly) | 812.76M |
| Debt to Equity Ratio | 0.1176 |
| Current Ratio | 7.110 |
| Net Debt Paydown Yield | 0.03% |